Regorafenib in Patients With Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Resound Trial: A phase 2 study of regorafenib in patients with thymoma (type B2-B3) and thymic carcinoma previously treated with chemotherapy
Cancer 2021 Oct 27;[EPub Ahead of Print], M Perrino, T De Pas, S Bozzarelli, L Giordano, F De Vincenzo, F Conforti, N Digiacomo, N Cordua, F D'Antonio, F Borea, A Santoro, PA ZucaliFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.